Mapping a Neutralizing Epitope on the SARS Coronavirus Spike Protein: Computational Prediction Based on Affinity-selected Peptides

Journal of Molecular Biology

Volumn 359, Issue 1, 2006, Pages 190-201

  Tarnovitski, Natalia ^a   Matthews, Leslie J ^b   Sui, Jianhua ^b   Gershoni, Jonathan M ^a   Marasco, Wayne A ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

antibody; computational algorithm; epitope; Mapitope; SARS

Indexed keywords

AMINO ACID; CYSTEINE; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; SARS CORONAVIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ALGORITHM; ARTICLE; CRYSTAL STRUCTURE; EPITOPE MAPPING; PHAGE DISPLAY; PREDICTION; PRIORITY JOURNAL; SARS CORONAVIRUS; THEORETICAL MODEL;

AVES; SARS CORONAVIRUS;

EID: 33646183714     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.03.008     Document Type: Article

References (41)

1. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nature Med. 10 (2004) 871-875
2. ter Meulen J., Bakker A.B., van den Brink E.N., Weverling G.J., Martina B.E., Haagmans B.L., et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363 (2004) 2139-2141
3. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl Acad. Sci. USA 101 (2004) 2536-2541
4. Smirnov Y.A., Gitelman A.K., Govorkova E.A., Lipatov A.S., and Kaverin N.V. Influenza H5 virus escape mutants: immune protection and antibody production in mice. Virus Res. 99 (2004) 205-208
5. Riberdy J.M., Flynn K.J., Stech J., Webster R.G., Altman J.D., and Doherty P.C. Protection against a lethal avian influenza A virus in a mammalian system. J. Virol. 73 (1999) 1453-1459
6. Gould L.H., Sui J., Foellmer H., Oliphant T., Wang T., Ledizet M., et al. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J. Virol. 79 (2005) 14606-14613
7. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Med. 11 (2005) 522-530
8. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., et al. A novel coronavirus associated with severe acute respiratory syndrome. New Engl. J. Med. 348 (2003) 1953-1966
9. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003) 1319-1325
10. Marra M.A., Jones S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.N., et al. The genome sequence of the SARS-associated coronavirus. Science 300 (2003) 1399-1404
11. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
12. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
13. Dimitrov D.S. The secret life of ACE2 as a receptor for the SARS virus. Cell 115 (2003) 652-653
14. Yang Z.Y., Werner H.C., Kong W.P., Leung K., Traggiai E., Lanzavecchia A., and Nabel G.J. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc. Natl Acad. Sci. USA 102 (2005) 797-801
15. Sette A., and Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15 (2003) 461-470
16. Enshell-Seijffers D., Denisov D., Groisman B., Smelyanski L., Meyuhas R., Gross G., et al. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J. Mol. Biol. 334 (2003) 87-101
17. Sui J., Li W., Roberts A., Matthews L.J., Murakami A., Vogel L., et al. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J. Virol. 79 (2005) 5900-5906
18. Tsodikov O.V., Record Jr. M.T., and Sergeev Y.V. Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J. Comput. Chem. 23 (2002) 600-609
19. Spiga O., Bernini A., Ciutti A., Chiellini S., Menciassi N., Finetti F., et al. Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem. Biophys. Res. Commun. 310 (2003) 78-83
20. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 (2005) 1864-1868
21. Shatsky M., Nussinov R., and Wolfson H.J. FlexProt: alignment of flexible protein structures without a predefinition of hinge regions. J. Comput. Biol. 11 (2004) 83-106
22. Wong S.K., Li W., Moore M.J., Choe H., and Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279 (2004) 3197-3201
23. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393 (1998) 648-659
24. Villard S., Lacroix-Desmazes S., Kieber-Emmons T., Piquer D., Grailly S., Benhida A., et al. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor. Blood 102 (2003) 949-952
25. Spiegel P.C., Jacquemin Jr. M., Saint-Remy J.M., Stoddard B.L., and Pratt K.P. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 98 (2001) 13-19
26. van den Brink E.N., Ter Meulen J., Cox F., Jongeneelen M.A., Thijsse A., Throsby M., et al. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J. Virol. 79 (2005) 1635-1644
27. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nature Med. 10 (2004) 871-875
28. Greenough T.C., Babcock G.J., Roberts A., Hernandez H.J., Thomas Jr. W.D., Coccia J.A., et al. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis. 191 (2005) 507-514
29. Zhang H., Wang G., Li J., Nie Y., Shi X., Lian G., et al. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J. Virol. 78 (2004) 6938-6945
30. Wang S., Chou T.H., Sakhatskyy P.V., Huang S., Lawrence J.M., Cao H., et al. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J. Virol. 79 (2005) 1906-1910
31. Keng C.T., Zhang A., Shen S., Lip K.M., Fielding B.C., Tan T.H., et al. Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. J. Virol. 79 (2005) 3289-3296
32. Myers M.A., Davies J.M., Tong J.C., Whisstock J., Scealy M., Mackay I.R., and Rowley M.J. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J. Immunol. 165 (2000) 3830-3838
33. Halperin I., Wolfson H., and Nussinov R. SiteLight: binding-site prediction using phage display libraries. Protein Sci. 12 (2003) 1344-1359
34. Dall'Acqua W., Goldman E.R., Lin W., Teng C., Tsuchiya D., Li H., et al. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry 37 (1998) 7981-7991
35. Venkatesh N., Krishnaswamy S., Meuris S., and Murthy G.S. Epitope analysis and molecular modeling reveal the topography of the C-terminal peptide of the beta-subunit of human chorionic gonadotropin. Eur. J. Biochem. 265 (1999) 1061-1066
36. Kolaskar A.S., and Kulkarni-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 261 (1999) 31-42
37. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., and Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 291-325
38. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 239 (1988) 476-481
39. Murphy B.R., Prince G.A., Walsh E.E., Kim H.W., Parrott R.H., Hemming V.G., et al. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 24 (1986) 197-202
40. Yu J., and Smith G.P. Affinity maturation of phage-displayed peptide ligands. Methods Enzymol. 267 (1996) 3-27
41. Matthews L.J., Davis R., and Smith G.P. Immunogenically fit subunit vaccine components via epitope discovery from natural peptide libraries. J. Immunol. 169 (2002) 837-846